Mohammad Hassan Ghadiani
Overview
Explore the profile of Mohammad Hassan Ghadiani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saburi E, Islami M, Hosseinzadeh S, Shapouri Moghadam A, Mansour R, Azadian E, et al.
Gene
. 2019 Feb;
696:72-79.
PMID: 30772518
Due to the several limitations that surgeons are faced during bone tissue implantation there are daily increases in introducing new cell-co-polymer composites for use in bone tissue engineering approaches. In...
2.
Gharehdaghi J, Abedi Khorasgani M, Ghadiani M, Kazemifar A, Solhi H, Solhi S
Adv Prev Med
. 2018 Jan;
2017:2043840.
PMID: 29318049
A large number of dead bodies are referred to forensic autopsy halls for medicolegal examination. They can be a source of transmission of infectious diseases through direct contact or autopsy...
3.
Jalalzadeh M, Ghadiani M
Iran J Kidney Dis
. 2017 Feb;
11(1):66-69.
PMID: 28174355
Treatment of snakebite complications is challenging, as it is difficult to distinguish what kind of antivenins should be used. Kidney failure as a result of rhabdomyolysis or hemolysis may happen...
4.
Jalalzadeh M, Mousavinasab N, Soloki M, Miri R, Ghadiani M, Hadizadeh M
Nephrourol Mon
. 2015 Mar;
7(1):e25560.
PMID: 25738129
Background: The metabolic syndrome (MeS) is a common risk factor for coronary heart disease (CHD) in the general population. Objectives: We examined the association between MeS and its risk in...
5.
Jalalzadeh M, Mousavinasab N, Peyrovi S, Ghadiani M
Nephrourol Mon
. 2015 Mar;
7(1):e24439.
PMID: 25738128
Background: Patients with end stage renal disease (ESRD) can be sustained with dialysis therapy. Objectives: In this study, we followed up the effect of early acute and late acute rejections...
6.
Jalalzadeh M, Ghadiani M, Mousavinasab N
J Nephropathol
. 2014 Jan;
1(3):170-6.
PMID: 24475411
Background: In dialysis patients, chronic infections have been associated with cachexia and anorexia. Objectives: This study was carried out to determine the association between Helicobacter pylori (HP) infection and body...
7.
Rostami Z, Einollahi B, Ghadiani M
Nephrourol Mon
. 2013 Nov;
5(3):835-9.
PMID: 24282796
Background: Improvement in the outcome of organ transplantation is related to advances in patient selection criteria, organ preservation, operative techniques, perioperative care and efficacy of immunosuppressive agents. Objectives: We aimed...
8.
Jalalzadeh M, Nurcheshmeh Z, Mohammadi R, Mousavinasab N, Ghadiani M
J Res Med Sci
. 2013 Jul;
17(11):1039-46.
PMID: 23833578
Background: Hyperuricemia has been associated with the development of high blood pressure (BP). We studied the effects of allopurinol therapy in hyperuricemic hemodialysis (HD) patients with high BP. Materials And...
9.
Beiraghdar F, Panahi Y, Einollahi B, Nemati E, Ghadiani M, Sahebkar A, et al.
Clin Lab
. 2012 Sep;
58(7-8):737-45.
PMID: 22997974
Background: Recombinant human erythropoietin (rHuEPO) is the cornerstone therapy for anemia associated with chronic kidney disease. However, not all patients with renal anemia receive sufficient doses of rHuEPO due to...
10.
Ghadiani M, Peyrovi S, Mousavinasab S, Jalalzadeh M
Arab J Nephrol Transplant
. 2012 Jan;
5(1):19-24.
PMID: 22283862
Introduction: Delayed Graft Function (DGF) is a common complication of renal transplants and the long-term relation between DGF and survival of patients and grafts is not well established. Methods: This...